https://www.selleckchem.com/products/brd3308.html
To the best of our knowledge, we are the first to report on a predominantly mild clinical manifestation entailing amnestic mild cognitive impairment in addition to depression, thus broadening the clinical spectrum associated with neurexin-3α antibodies.In this study, we investigated the clinical and genetic characteristics of 19 Korean patients with congenital stationary night blindness (CSN at two tertiary hospitals. Clinical evaluations, including fundus photography, spectral-domain optical coherence tomography, and electroretinogra
Like
Comment
Share
